Cost-effectiveness of population genomic screening
Genet Med
.
2019 Dec;21(12):2840-2841.
doi: 10.1038/s41436-019-0580-4.
Authors
David L Veenstra
1
,
Greg Guzauskas
2
,
Josh Peterson
3
,
Dina A Hassen
4
,
Susan Snyder
4
,
Jing Hao
4
,
Marc Williams
4
Affiliations
1
Department of Pharmacy, University of Washington, Seattle, WA, USA. veenstra@uw.edu.
2
Department of Pharmacy, University of Washington, Seattle, WA, USA.
3
Departments of Biomedical Informatics and Medicine, Vanderbilt University, Nashville, TN, USA.
4
Geisinger, Danville, PA, USA.
PMID:
31303645
DOI:
10.1038/s41436-019-0580-4
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Comment
MeSH terms
Cost-Benefit Analysis
Humans
Mass Screening*
Metagenomics*
Young Adult
Grants and funding
R01 HG009694/HG/NHGRI NIH HHS/United States